[Research progress of myocardial renin-angiotensin-aldosterone system]. 2019

P Z Wang, and S N Wen, and R Bai
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

P Z Wang, and S N Wen, and R Bai
July 2000, Cardiovascular research,
P Z Wang, and S N Wen, and R Bai
January 1992, Journal of cardiovascular pharmacology,
P Z Wang, and S N Wen, and R Bai
June 2004, Nihon rinsho. Japanese journal of clinical medicine,
P Z Wang, and S N Wen, and R Bai
July 1980, European journal of clinical pharmacology,
P Z Wang, and S N Wen, and R Bai
April 2007, Nihon rinsho. Japanese journal of clinical medicine,
P Z Wang, and S N Wen, and R Bai
February 2020, Current hypertension reports,
P Z Wang, and S N Wen, and R Bai
February 1981, Nihon rinsho. Japanese journal of clinical medicine,
P Z Wang, and S N Wen, and R Bai
November 1977, Deutsche medizinische Wochenschrift (1946),
P Z Wang, and S N Wen, and R Bai
May 2024, Pflugers Archiv : European journal of physiology,
P Z Wang, and S N Wen, and R Bai
September 1969, Kardiologiia,
Copied contents to your clipboard!